Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
Yi‐Chao Zheng(Ministry of Education), Hong‐Min Liu(Kailuan General Hospital), Ying‐Chao Duan, Xiaolin Zi(University of California, Irvine), Zhi-Ru Wang(Zhengzhou University), Xian-Wei Ye(Zhengzhou University), Shun Zhu(University of California, Irvine), Jinfeng Li(Hebei Medical University), Mengmeng Wang(Zhengzhou University), Junwei Wang(Guangzhou Institutes of Biomedicine and Health), Yanyan Zhu(Shandong Jianzhu University), Wen Zhao(Zhengzhou University), Jinlian Ma(Wenzhou Medical University), Wen-Lei Lv(Zhengzhou University), Rui-Min Xu(Zhengzhou University), David L. Mobley(University of California, Irvine)
Cited by 221
Related Papers
Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
|Journal of the American Chemical Society|2015|1.4k
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
|Molecular Cancer|2022|194
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
|Medicinal Research Reviews|2015|181